RLAY Stock Summary and Trading Ideas (Relay Therapeutics | NASDAQ:RLAY)

Relay Therapeutics Inc is a clinical-stage precision medicine company transforming the drug discovery process by combining leading-edge computational and experimental technologies with the goal of bringing life-changing therapies to patients. the Dynamo platform integrates an array of leading-edge computational and experimental approaches designed to drug-protein targets that have previously been intractable or inadequately addressed. The company is advancing a pipeline of medicine candidates to address targets in precision oncology and genetic disease, including product candidates, RLY-4008, RLY-2608, and GDC-1971 (formerly known as RLY-1971).

What symbol and exchange does Relay Therapeutics shares trade?

Relay Therapeutics trades on the NASDAQ stock market under the symbol RLAY.

What is Relay Therapeutics stock price doing today?

As of January 30, 2026, RLAY stock price declined to $7.66 with 1,157,717 million shares trading.

What is Relay Therapeutics's Beta?

RLAY has a beta of 1.99, meaning it tends to be more sensitive to market movements. RLAY has a correlation of 0.24 to the broad based SPY ETF.

How much is Relay Therapeutics worth?

RLAY has a market cap of $1.33 billion. This is considered a Small Cap stock.

How much money does Relay Therapeutics make?

Last quarter Relay Therapeutics reported $0 in Revenue and -$.43 earnings per share. This fell short of revenue expectation by $-332,000 and missed earnings estimates by -$.02.

What is the highest and lowest price Relay Therapeutics traded in the last 3 year period?

In the last 3 years, RLAY traded as high as $23.18 and as low as $1.78.

What are the top ETFs holding Relay Therapeutics?

The top ETF exchange traded funds that RLAY belongs to (by Net Assets): VTI, XBI, IWM, VXF, IWN.

Is Relay Therapeutics (RLAY) a good investment?

RLAY has outperformed the market in the last year with a price return of +68.7% while the SPY ETF gained +15.6%. RLAY has also outperformed the stock market ETF in the last 3 month and 2 week periods returning +4.4% and +4.2%, respectively, while the SPY returned +2.1% and 0.0%, respectively.

What are the support and resistance levels for Relay Therapeutics (RLAY)?

RLAY support price is $7.32 and resistance is $8.10 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that RLAY shares will trade within this expected range on the day.